J&J falls despite a beat-and-raise quarter. Why we’re raising our price target anyways

Johnson & Johnson shares fell Tuesday despite a mostly strong second-quarter earnings report and an increase to its full-year guidance. We’re not rattled by the

Tag: raising

J&J falls despite a beat-and-raise quarter. Why we’re raising our price target anyways

Biotech’s recovery isn’t a ‘head fake.’ These 3 stocks could lead the next leg up

Why severe wildfires are becoming more frequent in the UK and how to cope with the health risks

All the Cool Kids Are Birding

Pete Hegseth Wants YOU to Test Your Testosterone

What I Prioritize for a Healthy Metabolism

Why You Should Try Running Without a Fitness Tracker

Agitation in Dementia Can Be Helped by Medical Cannabis, Study Suggests